Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Dementia Treatment Market
Dementia Treatment Market size was valued at USD 17.7 billion in 2023 and is expected to exhibit growth at a CAGR of 7.6% from 2024 – 2032. High market growth can be attributed to the ongoing advancements in medical research, increasing prevalence of dementia, rising geriatric population, and growing demand for multimodal and personalized therapies, among other contributing factors.
Moreover, the global population is aging rapidly, with a significant increase in the proportion of older adults. Aging is the primary risk factor for dementia, and as the population ages, the prevalence of dementia is expected to rise. For instance, according to a recent United Nations (UN) research report, the number of people aged 65 and over globally is predicted to treble over the next three decades. The senior population is expected to reach 1.6 billion by 2050, accounting for more than 16% of the worldwide population.
This demographic trend creates a growing market for dementia treatments as the demand for effective therapies to manage symptoms and improve quality of life increases.
Dementia treatment refers to a broad range of therapeutic interventions aimed at managing the symptoms, slowing the progression, and improving the quality of life of individuals diagnosed with dementia. Dementia is a progressive neurodegenerative disorder characterized by cognitive decline, memory loss, impaired reasoning, and changes in behavior and personality.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Dementia Treatment Market Size in 2023: | USD 17.7 Billion |
Forecast Period: | 2024 – 2032 |
Forecast Period 2024 – 2032 CAGR: | 7.6% |
2024 – 2032 Value Projection: | USD 33.8 Billion |
Historical Data for: | 2021 – 2023 |
No. of Pages: | 110 |
Tables, Charts & Figures: | 150 |
Segments covered: | Drug Class, Indication, Route of Administration, Distribution Channel, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|